Advances in the Understanding of the Pathogenesis of Opportinistic Fungal Diseases. Zygomycosis George L. Petrikkos
|
|
- Cameron Owen
- 6 years ago
- Views:
Transcription
1 Advances in the Understanding of the Pathogenesis of Opportinistic Fungal Diseases. Zygomycosis George L. Petrikkos Professor of Internal Medicine and Infectious Disease National and Kapodistrian University of Athens Greece
2 Percentages of zygomycosis cases documented by culture since the 1940s, by decade Roden et al CID 2005:41
3 UK Netherlands Turkey Czech Republic Finland Norway Russia Spain Austria Belgium France Switzerland Germany Greece Italy G.Petrikkos, and the ECMM Zygomycosis Working Group, ICAAC, 2008.
4 Zygomycosis refers to a group of uncommon but frequently fatal mycoses caused by fungi of the class Zygomycetes. This class is subdivided into two orders,the Mucorales and the Entomophthorales. This disease is also sometimes referred to as mucormycosis,or phycomycosis but the term zygomycosis is preferred. 11/12/2010 4
5 The genera in the Order Mucorales cause most human infection. These organisms are ubiquitous in nature, and can be found on decaying vegetation,fruit, bread and in the soil. These fungi grow rapidly and release large numbers of spores that can become airborne.
6 All humans have ample exposure to these fungi during day-to-day activities. The fact that mucormycosis is a rare human infection reflects the effectiveness of the intact human immune system. This is further supported by the finding that almost all human infections due to a zygomycete occur in the presence of some underlying compromising condition.
7 Healthy humans have a strong natural immunity against Zygomycetes. Most commonly, the infection presents as an opportunistic disease in patients with underlying risk factors. 11/12/2010 7
8 The most important exception to this generalization is the disease caused by Entomophthorales, which commonly affects normal hosts. Other exceptions are rare reports of zygomycosis caused by the agents of the order Mucorales in immunocompetent individuals with no identifiable risk factors and in employees of both the malt and lumber industries. 11/12/2010 8
9 Cancer 5% Surgery 6% Solid organ transplantation 5% Burn 3% AIDS 1% Other 6% Trauma 10% Diabetes 10% Hematological Malignancy 54%
10 Underlying disease Mortality (%) Hematological malignancy 57.3 Diabetes 37.5 Trauma 12.5 Burn 20.0 Solid organ transplant 50.0 AIDS 0 Other 50.0 Surgery 50.0 Cancer 55.6 Total 47.8
11 The genera most commonly found in human infections are : Rhizopus, Mucor, and Rhizomucor; Cunninghamella, Absidia, Saksenaea, and Apophysomyces are genera that are less commonly implicated in infection.
12 Acrophialophora sp. 0% Rhizomucor 12% Mucor sp 30% Absidia sp. 19% Rhizopus sp 33% Cunninghamella sp 5% Apophysomyces sp 1%
13 Zygomycetes enter the human host through inhalation, percutaneous inoculation or ingestion Cutaneous infection following traumatic inoculation of a high load of sporangiospores under the skin is the most common form of zygomycosis in normal hosts.
14 Prolonged neutropenia Hyperglycemia and acidosis (DKA) Steroids Immunosuppressive therapy Burns, trauma (skin form) Excess iron Deferoxamine (not iron chelators in general) Voriconazole use?
15 Knowing the pathogenesis helps understand risk factors, manifestations and later on therapeutic implications
16 Intact mucosal and endothelial barriers serve as structural defenses against tissue invasion by Zygomycetes. The mechanisms of attachment to and invasion of mucosal surfaces have not been fully clarified. Spores may invade epithelium previously damaged by infection, cytotoxic chemotherapy or direct trauma. Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations and management. Infect Dis Clin N Am 2006;20:
17 Recent studies have suggested that zygomycetes sporangiospores may have unique capability for tissue adherence and invasion of intact endothelial barriers. A surprising finding is that viable spores are not essential for causing tissue damage and injection of heat-killed Rhizopus spp. can result in significant mortality in diabetic mice. This observation suggests that some component of sporangiospores may be directly toxic to endothelial cells in the mucosal membranes. Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations and management. Infect Dis Clin N Am 2006;20:
18 A greater understanding of the pathogenesis of the disease may lead to future therapies. For example, it is now clear that iron metabolism plays a central role in regulating mucormycosis infections and that deferoxamine predisposes patients to mucormycosis by inappropriately supplying the fungus with iron. Brad Spellberg, John Edwards Jr.,1 and Ashraf Ibrahim Clinical Microbiology Reviews, July 2005, p , Vol. 18, No. 3
19 To cause disease, the agents of mucormycosis must scavenge from the host sufficient iron for growth, must evade host phagocytic defense mechanisms, and must access vasculature to disseminate. Brad Spellberg,et al Clinical Microbiology Reviews, July 2005, p , Vol. 18, No. 3
20 A) In a normal host, primary defense mechanisms against mucormycosis include : Sequestration of iron in serum by specialized ironbinding proteins (1), phagocytes including circulating neutrophils (2a) and tissue macrophages (2b), and endothelial cells (3), which regulate vascular tone and permeability. Acting in concert, these mechanisms prevent establishment of infection in tissue and subsequent endovascular invasion. Brad Spellberg, John Edwards Jr., and Ashraf Ibrahim Clinical Microbiology Reviews, July 2005, p , Vol. 18, No. 3
21 B) In susceptible hosts, normal defense mechanisms break down. For example, in diabetic ketoacidosis (DKA), the acidic ph of the serum causes dissociation of free iron from sequestering proteins (1). This release of free iron allows rapid fungal growth. Defects in phagocytic defense mechanisms (2), for example, deficiency in cell number (neutropenia) or functional defects caused by corticosteroids or the hyperglycemia and acidosis of diabetic ketoacidosis, allow proliferation of the fungus. Finally, adherence to and damage of endothelial cells by the fungus (3) allows fungal angioinvasion and vessel thrombosis and subsequent tissue necrosis and dissemination of the fungal infection. Brad Spellberg, John Edwards Jr., and Ashraf Ibrahim Clinical Microbiology Reviews, July 2005, p , Vol. 18, No. 3
22 M. LIU, B. SPELLBERG, T. GEBREMARIAM, Y. FU, J. EDWARDS, JR., A. S. IBRAHIM; Habor-UCLA Med. Ctr., Torrance, CA. Identification of Rhizopus oryzae Ferrioxamine Receptor Conclusions: Our results suggest that we have identified inducible receptors for ferrioxamine. Further studies to confirm the role of these receptors in R. oryzae iron uptake from ferrioxamine and pathogenesis of mucormycosis is warranted.
23 Drosophila melanogaster flies injected with a standardized amount of fungal spores from clinical Zygomycetes isolates to study virulence & host defense mechanisms Chamilos G et al. PNAS; 2008 vol. 105 no. 27:
24 Zygomycetes rapidly infect and kill wild-type flies Toll-deficient flies exhibited susceptibility Constitutive overexpression of the antifungal peptide Drosomycin in transgenic flies partially restored resistance to zygomycosis Chamilos G et al. PNAS; 2008 vol. 105 no. 27:
25 Classic enhancers of Zygomycetes virulence corticosteroids increased iron supply & iron availability - treatment with deferoxamine dramatically Zygomycetes pathogenicity Chamilos G et al. PNAS; 2008 vol. 105 no. 27:
26 iron starvation induced by the iron chelator deferasirox significantly protected flies infected with Zygomycetes Chamilos G et al. PNAS; 2008 vol. 105 no. 27:
27 Chamilos G et al. PNAS; 2008 vol. 105 no. 27:
28 In normal hosts, the traumatic inoculation of a high load of sporangiospores under the skin leads to cutaneous zygomycosis. Extension to the subcutaneous tissue or bone is common in patients who have delayed or ineffectively treated cutaneous zygomycosis In immunocompromised patients the infection may disseminate.
29 Rhino-cerebral or cranio-facial (1/3-1/2 of the cases) Pulmonary Cutaneous Gastro-intestinal: rare Disseminated>90% mortality Others: endocarditis, kidneys, etc..
30 Predisposing conditions Clinical presentation Immunosuppression Respiratory tract infection, disseminated infection Metabolic Respiratory tract infection, rhinocerebral infection Deferoxamine therapy Disseminated infection Skin and soft tissue breakdown Primary cutaneous and soft tissue infection Intravenous illicit drug use Endocarditis, cerebral infection Neonatal prematurity Gastrointestinal infection, disseminated infection Malnourishment Gastrointestinal infection 11/12/
31 Acquired by the inhalation of spores Infection starts in the nasal turbinates then spreads to involve the orbits and the brain Mucor is angioinvasive and can lead to infarction of infected tissues
32
33 It occurs most frequently among neutropenic patients. It presents with nonspecific symptoms such as fever, cough and dyspnea; hemoptysis may occur with vascular invasion. Radiological presentation includes segmental consolidation that progresses to contiguous areas of the lung, with occasional cavitation. Fatality 80%
34 It has been reported with minor trauma, insect bites, contaminated dressings and patches, wounds, and burns. The necrotic lesions progressively evolve from the epidermis into dermis and even muscle and bone.
35 Minor trauma by lemon tree thorn. A patient who had a brother with soft tissue zygomycosis was taking care of him, changing the dressings. She had an abdominal scar due to previous cholecystectomy and she reported scratching it. She developed abdominal soft tissue zygomycosis. Petrikkos GL, Skiada A, Sambatakou H, et al. Mucormycosis: Ten year experience in a tertiarycare center in Greece. Eur J Clin Microbiol Infect Dis 2003;22:
36
37 Cutaneous zygomycosis in a patient with kidney transplantation
38 Needlestick exposures have been implicated in zygomycotic infections, occurring at the site of medicine injection, catheter insertion sites, injection sites for illicit drug use and tattooing. Insect bites or stings have also been implicated. Adam RD, Hunter G, DiTomasso J, Comerci G Jr.Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis 1994; 19:67 76.
39 Burrell SR, et al. Apophysomyces elegans infection associated with cactus spine injury in an immunocompetent pediatric patient. Pediatr Infect Dis J 1998; 17: Blair JE et al. Locally invasive cutaneous Apophysomyces elegans infection acquired from snapdragon patch test. Mayo Clin Proc 2002; 77: Nitroglycerin patch. Petrikkos et al. Eur J Clin Microbiol Infect Dis 2003;22:
40 «...His left index finger was swollen and tender, with multiple puncture wounds on the distal phalanx. There was loss of sensation and power in the left arm...» «C. bertholletiae was isolated from the pus swab of the patient s finger»
41
42 Intravenous intake of illicit drugs contaminated with Zygomycetes sporangiospores can produce disseminated and cerebral zygomycosis even in immunocompetent hosts.
43 Elasticized adhesive dressings Wooden tongue depressors Intravenous catheters Mead JH, Lupton GP, Dillavou CL, et al. Cutaneous Rhizopus infection. Occurrence as a postoperative complication associated with an elasticized adhesive dressing. JAMA 1979;242(3): Mitchell SJ, Gray J, Morgan ME, et al. Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors. Lancet 1996;348(9025):441 3.
44
45
46 Although the CVC was changed high fever persisted and discharge continued from the large abdominal wound. Repeated tampons in different sections and wound secretion smears were positive for A. corymbifera. Fluconazole was stopped and liposomal amphotericin (Ambisome; 5 mg/kg i.v.) given for over 3 months.
47 Zygomycosis of the scalp after a car accident
48 A volcanic cataclysm of major proportions, the fourth largest in terms of total casualties in the history of mankind, wiped out the town of Armero, Colombia, in 1985 resulting in over 23,000 deaths and 4,500 wounded. Among the hundreds of survivors who were transferred to hospitals in the capital city of Bogota, there was as overwhelming number who developed necrotizing fasciitis.
49 8 developed necrotizing fasciitis due to Rhizopus arrhizus. Only two survived.
50 Apophysomyces elegans
51 Invasive Fungal Disease (IFD) Following Remote Inoculation in Transplant Recipients E. M. PETSCHNIGG, F. M. MARTY, S. P. HAMMOND, V. T. HO, C. MAGEE, D. A. MILNER, J. H. ANTIN, L. R. BADEN.
52 E. M. PETSCHNIGG et all Two patients developed zygomycosis 2 and 10 months after their initial injuries. One patient sustained a penetrating injury while snowboarding and the other required surgical packing of a thigh abscess. Four and 23 days after transplantation respectively, both patients developed progressive necrotic skin lesions; angioinvasive hyphae consistent with Zygomycetes were seen on biopsy.
53 E. M. PETSCHNIGG et all Conclusions: Fungal organisms may remain latent after inoculation if plant debris or other foreign bodies are introduced during trauma. Subsequently, when significant immunosuppression is utilized, IFD may develop. IFD resulting from remote inoculation is a distinct syndrome that should be considered in immunocompromised patients presenting with soft tissue abnormalities in areas of prior injury.
54 Usually affects premature neonates and patients with severe malnutrition May involve the stomach, ileum, and colon Clinical picture mimics intra-abdominal abscess. The diagnosis is often made at autopsy
55 Clinical manifestations May involve virtually any organ Can spread from lungs, sinus, or rarely form the gastrointestinal tract Most commonly seen in people who are immunosuppressed, IV drug users, or hematological malignancies
56
57 . Mucormycosis is an increasingly common infection in immunocompromised patients. The central role of iron in the organism s pathogenesis has only recently been appreciated. The interaction between the Mucorales and endothelial cells is also beginning to be understood. Both of these pathogenetic features of disease may be amenable to novel therapeutic intervention in the future.
58
59 Iron overload Neutropenia Solid organ transplantation HIV Hypoglycemia
60 Zygomycosis is found only in immunosuppressed patients Diabetes mellitus is a risk factor for zygomycosis only if it is accompanied by diabetic ketoacidosis. Zygomycetes are the only fungi which can invade blood vessel walls. Zygomycosis can be transmitted by inhalation of spores Zygomycosis can be transmitted by blood transfusion.
Mucor Mycosis maxilla with palatal destruction An Interesting Case Report with Literature Review
ISSN 2250-0359 Volume 3 Issue 3.5 2013 Mucor Mycosis maxilla with palatal destruction An Interesting Case Report with Literature Review 1 Balasubramanian Thiagarajan 2 Venkatesan Ulaganathan 1 Stanley
More informationZygomycosesn existent plus.! Kwon-Chung et al. CID 2012
Zygomycosesn existent plus.! < Kwon-Chung et al. CID 2012 < Epidemiologyand treatmentof mucormycosis Olivier Lortholary, M.D.; Ph.D. Université Paris Descartes, Service de Maladies Infectieuses et Tropicales
More informationNovel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management
CLINICAL MICROBIOLOGY REVIEWS, July 2005, p. 556 569 Vol. 18, No. 3 0893-8512/05/$08.00 0 doi:10.1128/cmr.18.3.556 569.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved. Novel
More informationINTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIO-SCIENCE RHINOCEREBRAL MUCORMYCOSIS DUE TO RHIZOPUS IN A RECENTLY DIAGNOSED DIABETIC FEMALE: A CASE REPORT KULKARNI KV 1, PATHAK NP 2 1. Assistant
More informationZYGOMYCOSIS: AN UPDATE ON TREATMENT OPTIONS
Volume 24, Issue 4 January 2009 ZYGOMYCOSIS: AN UPDATE ON TREATMENT OPTIONS Erin Brady, Pharm.D. Candidate Zygomycosis, also referred to as Mucormycosis, is a rare angioinvasive fungal infection caused
More informationMycology. BioV 400. Subcutaneous Mycoses. Ecological associations. Geographic distribution World-wide
BioV 400 Mycology Handout 8 Subcutaneous Mycoses Lymphocutaneous sporotrichosis Chromoblastomycosis Phaeohyphomycosis Zygomycosis Mycetoma Lymphocutaneous sporotrichosis Sporothrix schenckii Chronic infection
More informationInvasive zygomycosis in neonates and children
REVIEW 10.1111/j.1469-0691.2009.02981.x Invasive zygomycosis in neonates and children E. Roilides 1,2, T. E. Zaoutis 3 5 and T. J. Walsh 2 1) 3rd Department of Paediatrics, Aristotle University, Thessaloniki,
More informationCase Studies in Fungal Infections and Antifungal Therapy
Case Studies in Fungal Infections and Antifungal Therapy Wayne L. Gold MD, FRCPC Annual Meeting of the Canadian Society of Internal Medicine November 4, 2017 Disclosures No financial disclosures or industry
More informationCase Report. Hypertension as the Presentation of Disseminated Rhizopus in an Infant with Acute Myeloid Leukaemia
HK J Paediatr (new series) 2018;23:29-33 Case Report Hypertension as the Presentation of Disseminated Rhizopus in an Infant with Acute Myeloid Leukaemia FL HUANG, CF LIN, PY CHEN, TK CHANG Abstract Key
More informationMucormycosis in renal transplant recipients: review of 174 reported cases
Song et al. BMC Infectious Diseases (2017) 17:283 DOI 10.1186/s12879-017-2381-1 RESEARCH ARTICLE Open Access Mucormycosis in renal transplant recipients: review of 174 reported cases Yan Song 1, Jianjun
More informationmycoses Prospective antifungal therapy (PATH) alliance â : focus on mucormycosis Summary Introduction
mycoses Diagnosis,Therapy and Prophylaxis of Fungal Diseases Original article Prospective antifungal therapy (PATH) alliance â : focus on mucormycosis Dimitrios P. Kontoyiannis, 1 Nkechi Azie, 2 Billy
More informationposaconazole, or prayers
Antifungal therapy: Polyenes, posaconazole, or prayers Michael Kleinberg, MD, PhD Associate Professor of Medicine Head, Infectious Diseases Section Marlene and Stewart Greenebaum Cancer Center University
More informationIntroduction. Study of fungi called mycology.
Fungi Introduction Study of fungi called mycology. Some fungi are beneficial: ex a) Important in production of some foods, ex: cheeses, bread. b) Important in production of some antibiotics, ex: penicillin
More informationNationwide survey of treatment for pediatric patients with invasive fungal infections in Japan
J Infect Chemother (2013) 19:946 950 DOI 10.1007/s10156-013-0624-7 ORIGINAL ARTICLE Nationwide survey of treatment for pediatric patients with invasive fungal infections in Japan Masaaki Mori Received:
More informationSevere mycosis as a rare infection after a corn auger injury of the hand: a case report
Bowles et al. Patient Safety in Surgery (2015) 9:22 DOI 10.1186/s13037-015-0061-x CASE REPORT Open Access Severe mycosis as a rare infection after a corn auger injury of the hand: a case report Richard
More informationSummary of the risk management plan (RMP) for Cresemba (isavuconazole)
EMA/576866/2015 Summary of the risk management plan (RMP) for Cresemba (isavuconazole) This is a summary of the risk management plan (RMP) for Cresemba, which details the measures to be taken in order
More informationOpportunistic Mycoses
CANDIDIASIS SOFYAN LUBIS DEPARTEMEN MIKROBIOLOGI FAK.KEDOKTERAN USU MEDAN 2009 Opportunistic Mycoses Opportunistic mycoses are fungal infections that do not normally cause disease in healthy people, but
More informationReview Article Invasive Mold Infections: Virulence and Pathogenesis of Mucorales
Microbiology Volume 2012, Article ID 349278, 5 pages doi:10.1155/2012/349278 Review Article Invasive Mold Infections: Virulence and Pathogenesis of Mucorales Giulia Morace and Elisa Borghi Department of
More informationManagement of fungal infection
Management of fungal infection HKDU symposium 17 th May 2015 Speaker: Dr. Thomas Chan MBBS (Hons), MRCP, FHKCP, FHKAM Synopsis Infection caused by fungus mycoses Skin infection by fungus is common in general
More informationGlobal epidemiology of cutaneous zygomycosis
Clinics in Dermatology (2012) 30, 628 632 Global epidemiology of cutaneous zygomycosis Anna Skiada, MD, PhD a,, Dimitris Rigopoulos, MD, PhD b, George Larios, MD, MSc c, George Petrikkos, MD, PhD d, Andreas
More informationCorrespondence should be addressed to Daniel Vikum;
Hindawi Case Reports in Infectious Diseases Volume 2017, Article ID 4173246, 4 pages https://doi.org/10.1155/2017/4173246 Case Report A Young, Immunocompetent Woman with Small Bowel and Hepatic Mucormycosis
More informationA prospective study of mucormycosis in north India: Experience from a tertiary care hospital
Medical Mycology, 2015, 53, 248 257 doi: 10.1093/mmy/myu086 Advance Access Publication Date: 13 January 2015 Original Article Original Article A prospective study of mucormycosis in north India: Experience
More informationDeadly Orbital Mucormycosis, Rare Yet Possible Infection
Medical Journal of Zambia, Volume 3 Number (2010) CASE REPORT Deadly Orbital Mucormycosis, Rare Yet Possible Infection 1 2 M K I Muma*, G Chipalo-Mutati 1 Eye Unit, Department of Surgery, University Teaching
More informationUnit 1: Asepsis and Infection Control
Unit 1: Asepsis and Infection Control Outlines - Type of microorganism causing infection. - Types of infection. - Nosocomial infection. - Chain of infection. - Body defenses against infection. - Factors
More informationFungal biology. Fungal Infections. Fungal cell structure. Pathogenesis
Fungal Infections Once exotic and rare; now increasingly common Fungi are not virulent But they are good at taking advantage Opportunistic in many senses Fungal biology Eukaryotic (organized nucleus and
More informationEpidemiology and ecology of fungal diseases
Epidemiology and ecology of fungal diseases Healthcare Focus on: - individual - diagnosis - treatment Public Health Focus on: - population - prevention The nature of fungi Kingdom Fungi (lat. fungus, -i)
More informationChapter 4 Inflammation and Infection
Chapter 4 Inflammation and Infection Defense Mechanisms Three lines of defense protect the body against foreign invasion: Physical or surface barriers Inflammation Immune response Inflammation Non-specific
More informationFungal biology. Pathogenesis. Fungal cell structure. Fungal Infections MID 25 & 26. Eukaryotic (organized nucleus and cell structure) Non-motile
Fungal Infections Once exotic and rare; now increasingly common Fungi are not virulent But they are good at taking advantage Opportunistic in many senses Fungal biology Eukaryotic (organized nucleus and
More informationPulmonary Infections: Fungus. Part I: Background Information and Dimorphic Fungus. Part II: Opportunistic Yeast and Molds
Pulmonary Infections: Fungus Part I: Background Information and Dimorphic Fungus Part II: Opportunistic Yeast and Molds Howard J. Sachs, MD www.12daysinmarch.com Classification: Unicellular Budding Yeast,
More informationPathogenesis of Infectious Diseases. CLS 212: Medical Microbiology
Pathogenesis of Infectious Diseases CLS 212: Medical Microbiology Definitions Path- means disease. Pathogenesis The steps or mechanisms involved in the development of a disease. Infection The presence
More informationREVIEW. Servicio de Hematología, Unidad de Enfermedades Infecciosas and Servicio de Microbiología, Hospital Universitario La Fe, Valencia, Spain
REVIEW Epidemiology of invasive fungal infections due to Aspergillus spp. and Zygomycetes M. A. Sanz Alonso, I. Jarque Ramos, M. Salavert Lletí, J. Pemán Servicio de Hematología, Unidad de Enfermedades
More information2 االستاذ المساعد الدكتور خالد ياسين الزاملي \ مناعة \ المرحلة الثانية \ التحليالت المرضية \
Innate Immunity Innate immunity: is the resistance that an individual possesses by birth. Innate immunity may be classified as (a) individual immunity (b) racial immunity (c) species immunity. Factors
More informationCase Report Mixed Fungal Infection (Aspergillus, Mucor,andCandida)of Severe Hand Injury
, Article ID 954186, 4 pages http://dx.doi.org/10.1155/2014/954186 Case Report Mixed Fungal Infection (Aspergillus, Mucor,andCandida)of Severe Hand Injury Milana Obradovic-Tomasev, 1,2 Aleksandra Popovic,
More informationUse of Antifungals in the Year 2008
Use of Antifungals in the Year 2008 Jose G. Montoya, MD Associate Professor of Medicine Associate Chief for Clinical Affairs Division of Infectious Diseases Stanford University School of Medicine Diagnosis
More informationUse of Antifungal Drugs in the Year 2006"
Use of Antifungal Drugs in the Year 2006" Jose G. Montoya, MD Associate Professor of Medicine Associate Chief for Clinical Affairs Division of Infectious Diseases Stanford University School of Medicine
More informationFoundations in Microbiology
Foundations in Microbiology Fifth Edition Talaro Chapter 13 Microbe Human Interactions: Infection and Disease Chapter 13 2 3 Infection a condition in which pathogenic microbes penetrate host defenses,
More informationFungal infection in the immunocompromised patient. Dr Kirsty Dodgson
Fungal infection in the immunocompromised patient Dr Kirsty Dodgson Aims Discuss different types of fungi Overview of types of clinical infections Clinical Manifestations Fungus Includes Moulds Aspergillus
More informationWhy is mucormycosis more difficult to cure than more common mycoses?
REVIEW 10.1111/1469-0691.12466 Why is mucormycosis more difficult to cure than more common mycoses? A. Katragkou 1,2, T. J. Walsh 2,3,4 and E. Roilides 1 1) Infectious Diseases Unit, 3rd Department of
More informationPathology of pulmonary tuberculosis. Dr: Salah Ahmed
Pathology of pulmonary tuberculosis Dr: Salah Ahmed Is a chronic granulomatous disease, caused by Mycobacterium tuberculosis (hominis) Usually it involves lungs but may affect any organ or tissue Transmission:
More informationFungi More or Less Obligately Associated with Humans. Requirements for Designating a Mycosis*
P Fungi More or Less Obligately Associated with Humans a. a few dermatophytes (the anthropophilic species ) b. Malassezia furfur c. Candida albicans d. + Lacazia (Loboa) loboi*p e. + Pneumocystis jirovecii*p
More informationMANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS
MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS Paul D. Holtom, MD Associate Professor of Medicine and Orthopaedics USC Keck School of Medicine Numbers of Cases of Sepsis in the United States, According
More informationnumber Done by Corrected by Doctor د.حامد الزعبي
number Fungi#1 Done by نرجس الس ماك Corrected by مهدي الشعراوي Doctor د.حامد الزعبي Introduction to Mycology -Terms: -Medical Mycology: The study of mycosis and their etiological agents -Mycosis: Disease
More informationBowel infarction due to intestinal mucormycosis in an immunocompetent patient
J Korean Surg Soc 2012;83:325-329 http://dx.doi.org/10.4174/jkss.2012.83.5.325 CASE REPORT JKSS Journal of the Korean Surgical Society pissn 2233-7903 ㆍ eissn 2093-0488 Bowel infarction due to intestinal
More informationInvasive Pulmonary Aspergillosis in
Infection & Sepsis Symposium Porto, April 1-3, 2009 Invasive Pulmonary Aspergillosis in Non-Immunocompromised Patients Stijn BLOT, PhD General Internal Medicine & Infectious Diseases Ghent University Hospital,
More informationGoal: Look for sources that require surgery in patients that present with severe infections.
High Risk EM Sukhjit Takhar, MD Assistant Clinical Professor of Emergency Medicine Faculty, Division of Infectious Disease UCSF-Fresno stakhar@fresno.ucsf.edu Goal: Look for sources that require surgery
More informationProphylaxis versus Diagnostics-driven approaches to treatment of Invasive fungal diseases. Y.L. Kwong Department of Medicine University of Hong Kong
Prophylaxis versus Diagnostics-driven approaches to treatment of Invasive fungal diseases Y.L. Kwong Department of Medicine University of Hong Kong Pathogenic yeast Candida Cryptococcus Trichosporon Pathogenic
More informationASPERGILLOSIS IN THE NON-NEUTROPENIC HOST
ASPERGILLOSIS IN THE NON-NEUTROPENIC HOST Dr J Garbino University Hospital Geneva ASPERGILLOSIS IN THE NON-NEUTROPENIC HOST INTRODUCTION SWISS ASPERGILLOSIS SURVEY IN THE NON-NEUTROPENIC HOST Introduction
More informationAntifungal Agents - Cresemba (isavuconazonium), Vfend. Prior Authorization Program Summary
Antifungal Agents - Cresemba (isavuconazonium), Noxafil (posaconazole), Vfend (voriconazole) Prior Authorization Program Summary FDA APPROVED INDICATIONS DOSAGE 1,2,14 Drug FDA Indication(s) Dosing Cresemba
More informationCase Report Successful Treatment of Recurrent Pulmonary Mucormycosis in a Renal Transplant Patient: A Case Report and Literature Review
Hindawi Case Reports in Transplantation Volume 2017, Article ID 1925070, 5 pages https://doi.org/10.1155/2017/1925070 Case Report Successful Treatment of Recurrent Pulmonary Mucormycosis in a Renal Transplant
More informationZygomycetes in Human Disease
CLINICAL MICROBIOLOGY REVIEWS, Apr. 2000, p. 236 301 Vol. 13, No. 2 0893-8512/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Zygomycetes in Human Disease JULIE A. RIBES,
More information2/18/19. Case 1. Question
Case 1 Which of the following can present with granulomatous inflammation? A. Sarcoidosis B. Necrobiotic xanthogranulma C. Atypical mycobacterial infection D. Foreign Body Reaction E. All of the above
More informationMANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSP There are no translations available. MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
More informationMucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment R. M. Prabhu 1 and R.
Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment R. M. Prabhu 1 and R. Patel 1,2 1 Division of Infectious Diseases and 2 Division of Clinical Microbiology,
More informationEMERGING FUNGAL INFECTIONS IN IMMUNOCOMPROMISED PATIENTS
EMERGING FUNGAL INFECTIONS IN IMMUNOCOMPROMISED PATIENTS DR LOW CHIAN YONG MBBS, MRCP(UK), MMed(Int Med), FAMS Consultant, Dept of Infectious Diseases, SGH Introduction The incidence of invasive fungal
More informationCommon Fungi. Catherine Diamond MD MPH
Common Fungi Catherine Diamond MD MPH Birth Month and Day & Last Four Digits of Your Cell Phone # BEFORE: http://tinyurl.com/kvfy3ts AFTER: http://tinyurl.com/lc4dzwr Clinically Common Fungi Yeast Mold
More informationSecond Joint Conference 0f the British HIV Association [BHIVA] and the British Association for Sexual Health and HIV [BASHH]
Second Joint Conference 0f the British HIV Association [BHIVA] and the British Association for Sexual Health and HIV [BASHH] 20-23 April 2010, Manchester Central Convention Complex SECOND JOINT CONFERENCE
More informationPharmacokinetics of Liposomal Amphotericin B in Pleural Fluid
AAC Accepts, published online ahead of print on 19 January 2010 Antimicrob. Agents Chemother. doi:10.1128/aac.01438-09 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationA case of malignant mucormycosis in a diabetic
Case report A case of malignant mucormycosis in a diabetic Dr. P.K. Satpathy, Dr. P.M. Diggikar, Dr. A. Patil, Dr. Priyanka Zagade, Dr. Mukund Wasekar, Dr. T. Venu Babu, Dr. Deepak Baldania. Name of Institute/College:
More informationUnusual Presentation of Pulmonary Mucormycosis in an Immunocompetent Patient
World Journal of Medical Sciences 14 (2): 47-51, 2017 ISSN 1817-3055 IDOSI Publications, 2017 DOI: 10.5829/idosi.wjms.2017.47.51 Unusual Presentation of Pulmonary Mucormycosis in an Immunocompetent Patient
More informationPROGRESSI NELLA TERAPIA ANTIFUNGINA. A tribute to Piero Martino
PROGRESSI NELLA TERAPIA ANTIFUNGINA A tribute to Piero Martino 1946-2007 ITALIAN ICONS IERI, OGGI, E DOMANI IERI, OGGI, E DOMANI IERI, OGGI, E DOMANI 1961 CAUSES OF DEATH IN PATIENTS WITH MALIGNANCIES
More informationChapter 7 8/23/2016. Asepsis and Infection Control. Asepsis. Asepsis (Cont.) Microorganisms. Infection control and prevention
Chapter 7 Asepsis and Infection Control All items and derived items 2015, 2011, 2006 by Mosby, Inc., an imprint of Elsevier Inc. All rights reserved. Asepsis Microorganisms Tiny microscopic entities capable
More informationHistopathology Description:
2013-2-1 CANINE HEART Ahmed M. Abubakar BOVINE PATHOLOGY CONTRIBUTING INSTITUTION : The Royal Veterinary college, Dept. of Pathology and Biology Signalment: 11-month-old male Border Collie dog (Canis familiaris)
More informationRheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement
Rheem Totah, Office H172M, Ph 206-543-9481 rtotah@uw.edu Office hours MWF 11:30 12:20 or by arrangement Date/Time Topic Readings Mon March 26 Antifungal agents Foye s Chapter 40 Wed March 28 Antifungal
More informationFungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia
Fungal infections in ICU Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia Epidemiology of invasive fungal infections - US +300% Martin GS, et al. N Engl J Med 2003;348:1546-1554
More informationTOWARDS PRE-EMPTIVE? TRADITIONAL DIAGNOSIS. GALACTOMANNAN Sensitivity 61% Specificity 93% Neg Predict Value >95% β-d-glucan Neg Predict Value 100% PCR
TOWARDS PRE-EMPTIVE? GALACTOMANNAN Sensitivity 61% Specificity 93% Neg Predict Value >95% TRADITIONAL DIAGNOSIS β-d-glucan Neg Predict Value 100% PCR diagnostics FUNGAL BURDEN FIRST TEST POSITIVE FOR ASPERGILLOSIS
More informationACCME/Disclosures. Two Patients and a Caveat 4/13/2016. Patient #1: 13 y/o boy with IPEX syndrome; s/p BMT
Two Patients and a Caveat The Use and Misuse of Molecular Methods in Mycobacterial Infections Gary W. Procop, MD Director, Molecular Microbiology Infectious Disease Pathologist Cleveland Clinic ACCME/Disclosures
More informationNecrotizing Enterocolitis: The Role of the Immune System
Necrotizing Enterocolitis: The Role of the Immune System Patricia Denning, M.D. Associate Professor in Pediatrics Division of Neonatology Emory University School of Medicine What is NEC? What is NEC? Necrotizing
More informationDimitrios P. Kontoyiannis, MD, ScD. Frances King Black Endowed Professor
Dimitrios P. Kontoyiannis, MD, ScD Frances King Black Endowed Professor Disclosures Research support from Merck, Pfizer and Astellas and has served as speaker for Gilead/Merck, Mylan, Inc and as consultant
More informationTailored Antifungal Modification in Breakthrough Mold Infections. Russell E. Lewis University of Bologna
Tailored Antifungal Modification in Breakthrough Mold Infections Russell E. Lewis University of Bologna 45 year-old patient with AML and documented pulmonary aspergillosis during remissioninduction chemotherapy
More informationPATHOGENICITY OF MICROORGANISMS
PATHOGENICITY OF MICROORGANISMS Some microorganisms are : 1- Harmless microorganism, as normal flora 2- Harmfull microorganism, as pathogenic. A pathogenic microorganism is defined as one that causes or
More informationImmunology. Anas Abu-Humaidan M.D. Ph.D. Transplant immunology+ Secondary immune deficiency
Immunology Anas Abu-Humaidan M.D. Ph.D. Transplant immunology+ Secondary immune deficiency Transplant Immunology Transplantation is the process of moving cells, tissues or organs from one site to another
More informationMedical Bacteriology- Lecture 10. Mycobacterium. Actinomycetes. Nocardia
Medical Bacteriology- Lecture 10 Mycobacterium Actinomycetes Nocardia 1 Mycobacterium Characteristics - Large, very weakly gram positive rods - Obligate aerobes, related to Actinomycetes - Catalase positive
More informationLecture 7: Mycoses Caused by Dimorphic Fungi, Part I
BIOL 4849 Medical Mycology Summer 2006 Histoplasmosis Lecture 7: Mycoses Caused by Dimorphic Fungi, Part I u Most common endemic mycotic disease in the United States u Two different varieties (actually
More informationInvasive Aspergillosis in Steroid-Treated Patients
Invasive Aspergillosis in Steroid-Treated Patients Dimitrios P. Kontoyiannis, MD, ScD Professor of Medicine Department of Infectious Diseases Infection Control and Employee Health PMN damaging Aspergillus
More informationMucormycosis: its contemporary face and management strategies
Mucormycosis: its contemporary face and management strategies Hsin-Yun Sun, Nina Singh Several countries have seen rising frequencies of mucormycosis among patients with haematological disorders, malignancies,
More informationInvasive Aspergillosis in India: Unique Challenges. Dr Rajeev Soman Consultant Physician PD Hinduja Hospital Mumbai
Invasive Aspergillosis in India: Unique Challenges Dr Rajeev Soman Consultant Physician PD Hinduja Hospital Mumbai Aspergillus Challenges Capable of surviving & thriving in all the diverse environmental
More informationECMM Excellence Centers Quality Audit
ECMM Excellence Centers Quality Audit Person in charge: Department: Head of Department: Laboratory is accredited according to ISO 15189 (Medical Laboratories Requirements for quality and competence) Inspected
More informationPneumocystis. Pneumocystis BIOL Summer Introduction. Mycology. Introduction (cont.) Introduction (cont.)
Introduction Pneumocystis Disclaimer: This lecture slide presentation is intended solely for educational purposes. Many of the images contained herein are the property of the original owner, as indicated
More informationWHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS?
WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS? Assoc. Prof. Dr. Serkan SENER Acibadem University Medical School Department of Emergency Medicine, Istanbul Acibadem Ankara Hospital,
More informationRole of iron in invasive fungal infections
Role of iron in invasive fungal infections Günter Weiss Department of Internal Medicine Clinical Immunology and Infectious Diseases Medical University of Innsbruck, Austria Iron at the host-pathogen-interface
More informationBIOH122 Session 8 Non-Specific Disease Resistance
BIOH122 Session 8 Non-Specific Disease Resistance To complete this worksheet, select: Module: Disease Resistance Activity: Animations Title: Non-Specific Disease Resistance Introduction 1. Name five general
More informationLung Abscess due to Clostridium barati in a Patient with Invasive Pulmonary Aspergillosis ACCEPTED
JCM Accepts, published online ahead of print on 3 January 2008 J. Clin. Microbiol. doi:10.1128/jcm.02446-07 Copyright 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationPulmonary mucormycosis is a relatively uncommon
Case Report Medical Ablation of Endobronchial Mucormycosis with Amphotericin-B Darsana Viswam*, VP Gopinathan+, Kumari Indira**, Shalini Vinod***, Natasha Sasankan*** Abstract A 56 years male diabetic
More informationImmunology Lecture 4. Clinical Relevance of the Immune System
Immunology Lecture 4 The Well Patient: How innate and adaptive immune responses maintain health - 13, pg 169-181, 191-195. Immune Deficiency - 15 Autoimmunity - 16 Transplantation - 17, pg 260-270 Tumor
More informationBacterial Mechanisms of Pathogenicity
Bacterial Mechanisms of Pathogenicity 1 st Lecture Introduction Infection and Disease A. Definitions B. Generalized Stages of Infection C. Virulence Factors and Toxins A. Definitions Disease and Infectious
More informationPrinciples of Disease and Epidemiology
Principles of Disease and Epidemiology Symbiosis living together An association between two or more species and one species is typically dependent on the other Mutualism - Commensalism - Parasitism - Infection
More informationUnit 23: Immunity from Disease
Unit 5 The Human Body Unit 23 Immunity from Disease- Unit 23: Immunity from Disease Name: Period: Page 1 of 51 Unit 5 The Human Body Unit 23 Immunity from Disease- Chapter 23 assignments Pages/Sections
More informationMedical APMLE. Podiatry and Medical.
Medical APMLE Podiatry and Medical http://killexams.com/exam-detail/apmle Question: 290 Signs and symptoms of hemolytic transfusion reactions include: A. Hypothermia B. Hypertension C. Polyuria D. Abnormal
More informationNonspecific External Barriers skin, mucous membranes
Immune system Chapter 36 BI 103 Plant-Animal A&P Levels of Defense Against Disease Nonspecific External Barriers skin, mucous membranes Physical barriers? Brainstorm with a partner If these barriers are
More informationImmunocompromised patients. Immunocompromised patients. Immunocompromised patients
Value of CT in Early Pneumonia in Immunocompromised Patients Nantaka Kiranantawat, PSU Preventative Factors Phagocyts Cellular immunity Humoral immunity Predisposing Factors Infection, Stress, Poor nutrition,
More informationHAEMATOLOGY ANTIFUNGAL POLICY
HAEMATOLOGY ANTIFUNGAL POLICY PROPHYLAXIS Primary Prophylaxis Patient Group Patients receiving intensive remissioninduction chemotherapy for Acute Leukaemia (excluding patients receiving vinca alkaloids)
More informationFungi GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER NUMBER 53: Fungi Author Moi Lin Ling, MBBS, FRCPA, CPHQ, MBA Chapter Editor Ziad A. Memish, MD, FRCPC, FACP Cover heading - Topic Outline Topic outline
More informationCase Report Carotid Artery Occlusion by Rhinoorbitocerebral Mucormycosis
Case Reports in Surgery Volume 2012, Article ID 812420, 4 pages doi:10.1155/2012/812420 Case Report Carotid Artery Occlusion by Rhinoorbitocerebral Mucormycosis Faisal Al-Otaibi, 1 Monirah Albloushi, 2
More informationCASE REPORT A CASE OF RHINO-ORBITAL MUCORMYCOSIS IN A PATIENT WITH UNCONTROLLED TYPE 2 DIABETES MELLITUS
A CASE OF RHINO-ORBITAL MUCORMYCOSIS IN A PATIENT WITH UNCONTROLLED TYPE 2 DIABETES MELLITUS Vikas L 1, Ranjith V 2, Riyaz Ahmed 3, Surakshith T.K 4 HOW TO CITE THIS ARTICLE: Vikas L, Ranjith V, Riyaz
More informationNIH Public Access Author Manuscript Clin Infect Dis. Author manuscript; available in PMC 2009 December 15.
NIH Public Access Author Manuscript Published in final edited form as: Clin Infect Dis. 2008 August 1; 47(3): 364 371. doi:10.1086/589857. Combination Polyene-Caspofungin Treatment of Rhino-Orbital- Cerebral
More informationSuccessful treatment of larynxtracheobronchial-pulmonary
Case Report Successful treatment of larynxtracheobronchial-pulmonary aspergillosis in an immunocompetent host W.X. Qu, X.W. Feng and L. Zhao The First Respiratory Department of Shengjing Hospital, China
More informationI. Lines of Defense Pathogen: Table 1: Types of Immune Mechanisms. Table 2: Innate Immunity: First Lines of Defense
I. Lines of Defense Pathogen: Table 1: Types of Immune Mechanisms Table 2: Innate Immunity: First Lines of Defense Innate Immunity involves nonspecific physical & chemical barriers that are adapted for
More informationYersinia pestis. Yersinia and plague. Dr. Hala Al Daghistani
Yersinia pestis Dr. Hala Al Daghistani Yersinia species Short, pleomorphic gram-negative rods that can exhibit bipolar staining. Catalase positive, and microaerophilic or facultatively anaerobic. Animals
More informationImmunodeficiencies HIV/AIDS
Immunodeficiencies HIV/AIDS Immunodeficiencies Due to impaired function of one or more components of the immune or inflammatory responses. Problem may be with: B cells T cells phagocytes or complement
More information